Key result
Ambulatory blood pressure monitoring provides unique clinical information on 24-hour blood pressure profiles and treatment responses, justifying its cautious use in selected hypertensive patients.
Why the study?
Does ambulatory blood pressure monitoring improve the diagnostic and prognostic evaluation of hypertensive patients compared to clinical or home measurements?
Does ambulatory blood pressure monitoring improve the diagnostic and prognostic evaluation of hypertensive patients compared to clinical or home measurements?
Answers are grounded in this paper and cite their sources.
Ambulatory blood pressure monitoring offers unique diagnostic and prognostic insights, such as 24-hour profiles and variability, supporting its targeted use in clinical practice.
In this issue of the journal, Palatini [1] summarizes the evidence that ambulatory blood pressure monitoring is superior to clinical blood pressure in the diagnostic and prognostic evaluation of hypertensive patients. However, some inherent limitations of the techniques employed for ambulatory blood pressure monitoring are also emphasized, including the likelihood of artefactual readings which are often disregarded in the context of an uncritical use in clinical practice. On this background, the current indications for ambulatory blood pressure monitoring in hypertension (e.g. the identification of patients with isolated office hypertension) are discussed vis-à-vis the possible role of alternative approaches, and somewhat negative conclusions are reached. That is, that ambulatory blood pressure monitoring does not have clear advantages over multiple clinical measurements or self blood pressure monitoring at home. As a consequence, a suggestion is made to limit the clinical use of ambulatory blood pressure recording only to those expert centres able to guarantee high quality tracings and an appropriate interpretation of the results, and to restrict its application to carefully selected cases. We agree with most of the points made in this review, which is in line with the caution recommended by the WHO/ISH and JNC VI Guidelines [2,3] and with our own advice to temper the enthusiasm for this approach, pending collection of conclusive evidence on its advantages and superiority over properly used clinical and home blood pressure measurements [4–7]. However, as Palatini himself acknowledges, proper concern for the overuse of ambulatory blood pressure monitoring in clinical practice should not lead to an underestimation of the enormous potential of this approach, as well as its important role not only in cardiovascular research, but also in the management of selected, but by no means less relevant, clinical cases [8]. This is for two reasons. First, although multiple and carefully performed clinical blood pressure measurements may indeed reach a diagnostic power similar to that of 24-h, day or night-time average blood pressure values [9,10], this rarely materializes in practice, due to the very short duration of the physician's visit [11]. It has been reported that, on average, a physician's visit lasts 6–10 min, which does not even come close to the time necessary for multiple clinical blood pressure measurements to be properly obtained. Furthermore, notwithstanding the limitations emphasized by Palatini, ambulatory blood pressure monitoring allows information to be collected that may be clinically relevant over and above the information provided by other blood pressure measuring techniques. For example, only ambulatory blood pressure monitoring provides data on the 24-h blood pressure profile and on its derangement in disease [8,12–14]. When its reproducibility is documented, this derangement may offer information that quantifies cardiovascular risk and, in higher risk patients, allows timely implementation of the more aggressive therapeutic measures that these patients require. Furthermore, only ambulatory blood pressure monitoring allows blood pressure variability over the day and night to be detected, thereby providing a parameter that may have an independent prognostic value [13,15–18]. Although only accurate when beat-to-beat invasive [19] or non-invasive [20,21] blood pressure monitoring methods are employed [22], quantification of blood pressure variability may also be acceptable with the commonly employed automated ambulatory blood pressure recorders, through which the clinical importance of blood pressure variability was recently confirmed [16,17,23]. Moreover, only ambulatory blood pressure monitoring may cast some light on symptomatic episodes that occur over 24 h, either because of blood pressure increases or of blood pressure reductions. This approach may be usefully employed not only in the diagnosis of hypertension, but also when evaluating the rate and the severity of hypotensive episodes. In addition, this method, by definition, is the only available tool to identify and manage those patients with so-called ‘isolated ambulatory hypertension', a condition that is less rare than once thought, and that may have an adverse impact on organ damage [24]. Finally, it should not be forgotten that ambulatory blood pressure monitoring may offer a more precise evaluation of the blood pressure response to antihypertensive treatment than clinic blood pressure does [25–27]. This is because ambulatory blood pressure monitoring is largely devoid of a placebo effect [28] and because the 24-h average blood pressure is more reproducible than isolated clinical measurements, thus avoiding a regression to the mean phenomenon [29,30]. An additional factor is the absence of any ‘white coat effect’ when automated blood pressure measurements are employed [31]. This offers a considerable advantage over clinical measurements, because the white coat effect that characterizes the latter may unpredictably attenuate over time in different subjects, and this may interfere with an accurate assessment of the actual effect of antihypertensive treatment. If ambulatory blood pressure monitoring may represent a useful tool in clinical practice in selected cases, it is widely acknowledged as a unique tool to investigate the 24-h effects of new antihypertensive agents in drug studies [32]. In this context, a few mathematical indices have been proposed to help assess the homogeneity of blood pressure reduction induced by antihypertensive treatment over 24 h, such as the trough-to-peak ratio [33,34] and the smoothness index [35]. The latter appears to be particularly useful insofar as it can be used in individual subjects to quantify the degree and the smoothness of their 24-h blood pressure coverage, and it has been shown to negatively correlate with the degree of blood pressure variability during treatment [35]. In conclusion, although a number of possible advantages of ambulatory blood pressure monitoring still appear to be a research issue, this should not prevent the cautious use of this technique in clinical practice, on the background of the available evidence suggesting that it could indeed provide a better approach to hypertension management.
No takes yet. Share an insight, caveat, or question.
Parati et al. (2002) conducted an editorial in Hypertension. Ambulatory blood pressure monitoring vs. Clinical blood pressure measurements or self blood pressure monitoring at home was evaluated. Ambulatory blood pressure monitoring provides unique clinical information on 24-hour blood pressure profiles and treatment responses, justifying its cautious use in selected hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: